Dolby Laboratories (DLB) Stock Price, News & Analysis

Company Overview

Dolby Laboratories, Inc. (NYSE: DLB) is a global technology company that develops audio, imaging, and voice solutions for entertainment, communication, and enterprise applications. Founded in 1965 by Ray Dolby, the company first gained recognition for its pioneering noise-reduction system in analog recordings and cinema, and has since evolved into a leading licensor of advanced multimedia technologies. Dolby’s innovations aim to elevate the quality of sound and visuals across a broad range of platforms, from theatrical releases and home theaters to mobile devices and virtual reality.

The company’s flagship offerings include Dolby Atmos, an immersive audio format that enables three-dimensional sound in cinemas, homes, and on personal devices, and Dolby Vision, a high dynamic range (HDR) imaging technology that enhances contrast and color accuracy. Beyond these marquee products, Dolby provides a suite of solutions such as Dolby Digital, Dolby Audio, and Dolby Voice, which are integrated into televisions, smartphones, game consoles, laptops, and professional production equipment. Licensees implement Dolby’s technologies through system-on-chip (SoC) designs, software development kits, and cloud-based services.

Dolby serves a geographically diverse customer base, partnering with major motion picture studios, streaming platforms, broadcasters, and consumer electronics manufacturers across North America, Europe, Asia-Pacific, Latin America, and emerging markets. The company’s technologies are featured in thousands of movie theaters worldwide, as well as in leading streaming services, gaming consoles, automotive infotainment systems, and teleconferencing solutions. Dolby’s collaborations with industry leaders help drive the adoption of immersive media experiences.

Headquartered in San Francisco, Dolby Laboratories is led by CEO Kevin Yeaman and a global executive team focused on research and development, strategic partnerships, and intellectual property licensing. Building on decades of engineering expertise, the company continues to invest in next-generation audio and imaging innovations to meet evolving consumer and professional demands, with an eye toward expanding its presence in live events, virtual and augmented reality, and connected car environments.

Key Stats

• Today's Range: $74.99 to $75.70
• 50-Day Range: $72.25 to $77.69
• 52-Week Range: $66.35 to $89.66
• Volume: 278,499 shs
• Average Volume: 451,990 shs
• Market Capitalization: $7.21 billion
• P/E Ratio: 28.33
• Dividend Yield: 1.76%
• Price Target: $102.33
• Consensus Rating: Buy

Dolby Laboratories Stock Analysis - MarketRank™

Dolby Laboratories scored higher than 99% of companies evaluated by MarketBeat, and ranked 4th out of 291 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Dolby Laboratories has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Dolby Laboratories has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 8.16%

Earnings Growth

Earnings for Dolby Laboratories are expected to grow by 8.16% in the coming year, from $2.94 to $3.18 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Dolby Laboratories is 28.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.85.

Price to Earnings Ratio vs. Sector

The P/E ratio of Dolby Laboratories is 28.33, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 21.33.

Price to Book Value per Share Ratio

Dolby Laboratories has a P/B Ratio of 2.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.33% of the float of Dolby Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Dolby Laboratories has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Dolby Laboratories has recently increased by 14.63%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Dolby Laboratories pays a meaningful dividend of 1.76%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Dolby Laboratories has been increasing its dividend for 10 years.

Dividend Coverage

The dividend payout ratio of Dolby Laboratories is 49.81%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 41.51% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.5 / 5
• Environmental Score: -0.42

Percentage of Shares Shorted

2.33% of the float of Dolby Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Dolby Laboratories has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Dolby Laboratories has recently increased by 14.63%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.16

News Sentiment

Dolby Laboratories has a news sentiment score of 1.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.86 average news sentiment score of Consumer Discretionary companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Dolby Laboratories this week, compared to 7 articles on an average week.

Search Interest

3 people have searched for DLB on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Dolby Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,593,770.00 in company stock.

Percentage Held by Insiders

38.39% of the stock of Dolby Laboratories is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

58.56% of the stock of Dolby Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DLB Stock Analysis - Frequently Asked Questions

How have DLB shares performed this year?

Dolby Laboratories' stock was trading at $78.10 at the beginning of 2025. Since then, DLB shares have decreased by 3.9% and is now trading at $75.07.

How were Dolby Laboratories' earnings last quarter?

Dolby Laboratories (NYSE:DLB) posted its quarterly earnings data on Thursday, May, 1st. The electronics maker reported $1.34 EPS for the quarter, topping analysts' consensus estimates of $1.29 by $0.05. The company's revenue was up 1.4% on a year-over-year basis.
Read the conference call transcript.

How will Dolby Laboratories' stock buyback program work?

Dolby Laboratories' board authorized a stock repurchase program on Wednesday, August 7th 2024, which authorizes the company to repurchase $350,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 5% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board believes its shares are undervalued.

Does Dolby Laboratories have any subsidiaries?

Dolby Laboratories subsidiaries include Voxeet, Doremi Labs, Step Labs, Coding Technologies, Dolby International AB, and Dolby Laboratories Licensing Corporation.

Who are Dolby Laboratories' major shareholders?

Dolby Laboratories' top institutional investors include Assenagon Asset Management S.A. (0.04%), Wealth Enhancement Advisory Services LLC (0.02%), Mitchell & Pahl Private Wealth LLC (0.02%) and Exchange Traded Concepts LLC (0.01%). Insiders that own company stock include John D Couling, Kevin J Yeaman, Mark Andrew Sherman, Todd Pendleton, Simon Segars, Ryan Nicholson, Anjali Sud and Emily Rollins.
View institutional ownership trends.

How do I buy shares of Dolby Laboratories?

Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Dolby Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Dolby Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

• Last Earnings: 5/01/2025
• Record date for 5/21 Dividend: 5/13/2025
• Ex-Dividend for 5/21 Dividend: 5/13/2025
• Dividend Payable: 5/21/2025
• Today: 7/13/2025
• Next Earnings (Estimated): 7/31/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Discretionary
• Industry: AUDIO/VIDEO PRD
• Sub-Industry: Electronic Components
• Current Symbol: NYSE:DLB
• CIK: 1308547
• Web: www.dolby.com
• Phone: (415) 558-0200
• Fax: 415-645-4000
• Employees: 2,080
• Year Founded: 1965

Price Target and Rating

• Average Price Target for Dolby Laboratories: $102.33
• High Price Target: $112.00
• Low Price Target: $95.00
• Potential Upside/Downside: +36.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.65
• Trailing P/E Ratio: 28.33
• Forward P/E Ratio: 25.53
• P/E Growth: N/A
• Net Income: $261.83 million
• Net Margins: 19.44%
• Pretax Margin: 23.95%
• Return on Equity: 11.48%
• Return on Assets: 9.24%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.04
• Quick Ratio: 2.96

Sales & Book Value

• Annual Sales: $1.27 billion
• Price / Sales: 5.66
• Cash Flow: $3.75 per share
• Price / Cash Flow: 20.00
• Book Value: $26.06 per share
• Price / Book: 2.88

Miscellaneous

• Outstanding Shares: 96,070,000
• Free Float: 59,186,000
• Market Cap: $7.21 billion
• Optionable: Optionable
• Beta: 0.91